These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1014 related items for PubMed ID: 31277702

  • 41. Downregulation of Annexin A11 (ANXA11) Inhibits Cell Proliferation, Invasion, and Migration via the AKT/GSK-3β Pathway in Gastric Cancer.
    Hua K, Li Y, Zhao Q, Fan L, Tan B, Gu J.
    Med Sci Monit; 2018 Jan 07; 24():149-160. PubMed ID: 29306955
    [Abstract] [Full Text] [Related]

  • 42. Long noncoding RNA OIP5-AS1 targets Wnt-7b to affect glioma progression via modulation of miR-410.
    Sun WL, Kang T, Wang YY, Sun JP, Li C, Liu HJ, Yang Y, Jiao BH.
    Biosci Rep; 2019 Jan 31; 39(1):. PubMed ID: 30498093
    [Abstract] [Full Text] [Related]

  • 43. Berberine Sensitizes Human Ovarian Cancer Cells to Cisplatin Through miR-93/PTEN/Akt Signaling Pathway.
    Chen Q, Qin R, Fang Y, Li H.
    Cell Physiol Biochem; 2015 Jan 31; 36(3):956-65. PubMed ID: 26087719
    [Abstract] [Full Text] [Related]

  • 44. MicroRNA-133b inhibits proliferation and invasion of ovarian cancer cells through Akt and Erk1/2 inactivation by targeting epidermal growth factor receptor.
    Liu X, Li G.
    Int J Clin Exp Pathol; 2015 Jan 31; 8(9):10605-14. PubMed ID: 26617770
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. CHN1 promotes epithelial-mesenchymal transition via the Akt/GSK-3β/Snail pathway in cervical carcinoma.
    Zhao H, Wang L, Wang S, Chen X, Liang M, Zhang X, Wang J, Xu X.
    J Transl Med; 2021 Jul 08; 19(1):295. PubMed ID: 34238315
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. LncRNA LINC00342 regulated cell growth and metastasis in non-small cell lung cancer via targeting miR-203a-3p.
    Chen QF, Kong JL, Zou SC, Gao H, Wang F, Qin SM, Wang W.
    Eur Rev Med Pharmacol Sci; 2019 Sep 08; 23(17):7408-7418. PubMed ID: 31539128
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
    Kong LY, Xue M, Zhang QC, Su CF.
    Oncotarget; 2017 Feb 28; 8(9):15507-15519. PubMed ID: 28099945
    [Abstract] [Full Text] [Related]

  • 55. Silencing dishevelled-1 sensitizes paclitaxel-resistant human ovarian cancer cells via AKT/GSK-3β/β-catenin signalling.
    Zhang K, Song H, Yang P, Dai X, Li Y, Wang L, Du J, Pan K, Zhang T.
    Cell Prolif; 2015 Apr 28; 48(2):249-58. PubMed ID: 25643607
    [Abstract] [Full Text] [Related]

  • 56. Effect of siRNA-silencing of SALL2 gene on growth, migration and invasion of human ovarian carcinoma A2780 cells.
    Miao F, Zhang X, Cao Y, Wang Y, Zhang X.
    BMC Cancer; 2017 Dec 11; 17(1):838. PubMed ID: 29228922
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Regulatory mechanism of lncRNA NORAD on proliferation and invasion of ovarian cancer cells through miR-199a-3p.
    Xu C, Zhu LX, Sun DM, Yao H, Han DX.
    Eur Rev Med Pharmacol Sci; 2020 Feb 11; 24(4):1672-1681. PubMed ID: 32141533
    [Abstract] [Full Text] [Related]

  • 60. Targeting of GSK-3β by miR-214 to facilitate gastric cancer cell proliferation and decrease of cell apoptosis.
    Li HL, Liang S, Cui JH, Han GY.
    Eur Rev Med Pharmacol Sci; 2018 Jan 11; 22(1):127-134. PubMed ID: 29364479
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 51.